Pennington M E, Lam K S, Cress A E
Department of Radiation Oncology, University of Arizona, Tucson 85824, USA.
Mol Divers. 1996 Oct;2(1-2):19-28. doi: 10.1007/BF01718696.
Tumor cell progression is dependent in part on the successful adhesive interactions of the cells with the extracellular matrix. In this study, a new approach is described to isolate linear peptide ligand candidates involved in cellular adhesion. A synthetic combinatorial peptide library based on the 'one-bead-one-peptide' concept was incubated with live human prostate cancer cells for 90 min at 37 degrees C. The peptide bead coated with a monolayer of cells was then isolated for microsequencing. The DU145 (DU-H) cells were chosen since they have been previously characterized as containing elevated levels of a laminin receptor for cell adhesion, the alpha 6 beta 1 integrin on the cell surface. The use of a function-blocking antibody (GoH3) allows for the detection of peptides which are alpha 6-specific ligand candidates. From two different libraries (linear 9-mer and 11-mer) of a total of 1,500,000 beads, 68 peptide beads containing attached cells were isolated. These positive beads were then retested to determine the ability of the GoH3 antibody to block binding of the cells to the peptide beads. The alpha 6 integrin candidate peptide beads (five in total) were recovered and two of the beads were microsequenced. These two peptides, RU-1 (LNIVS-VNGRHX) and RX-1 (DNRIRLQAKXX), resemble the previously reported active peptide sequences (GD-2 and AG-73) from native laminin. The RU-1, RX-1 and AG-73 peptides were tested for their ability to support cell attachment and to bind the cell surface of DU-H prostate carcinoma cells in suspension using fluorescence-activated cell-sorting (FACS) analysis. Both RU-1 and AG-73 peptides supported cellular attachment within 1 h. In contrast, after 1 h, EHS laminin supported both cellular attachment and spreading. The RX-1 peptide exhibited only weak binding to the DU-H prostate carcinoma cells. FACS analysis indicated that AG-73 peptide attached to tumor cell surfaces over a range of concentrations, whereas the RU-1 peptide showed a homogeneous concentration required for attachment. The described strategy for screening a random peptide library offers three advantages: (i) ligands for conformationally sensitive receptors of adhesion can be isolated using live cells; (ii) specific binding can be selected for using function-blocking antibodies; and (iii) peptides supporting adhesion independent of spreading properties can be distinguished. In principle, specific adhesive peptides without prior knowledge of the sequence could be isolated for any epithelial cell surface receptor for which a function-blocking reagent is available.
肿瘤细胞的进展部分取决于细胞与细胞外基质成功的黏附相互作用。在本研究中,描述了一种分离参与细胞黏附的线性肽配体候选物的新方法。基于“一珠一肽”概念的合成组合肽库在37℃下与活的人前列腺癌细胞孵育90分钟。然后分离出包被有单层细胞的肽珠用于微量测序。选择DU145(DU-H)细胞是因为它们先前已被鉴定为含有高水平的用于细胞黏附的层粘连蛋白受体,即细胞表面的α6β1整合素。使用功能阻断抗体(GoH3)可检测作为α6特异性配体候选物的肽。从总共150万个珠子的两个不同文库(线性9肽和11肽)中,分离出68个含有附着细胞的肽珠。然后对这些阳性珠子进行重新测试,以确定GoH3抗体阻断细胞与肽珠结合的能力。回收了α6整合素候选肽珠(总共5个),并对其中两个珠子进行了微量测序。这两个肽,RU-1(LNIVS-VNGRHX)和RX-1(DNRIRLQAKXX),类似于先前报道的来自天然层粘连蛋白的活性肽序列(GD-2和AG-73)。使用荧光激活细胞分选(FACS)分析测试了RU-1、RX-1和AG-73肽支持细胞附着以及结合悬浮的DU-H前列腺癌细胞细胞表面的能力。RU-1和AG-73肽在1小时内都支持细胞附着。相比之下,1小时后,EHS层粘连蛋白既支持细胞附着又支持细胞铺展。RX-1肽仅表现出与DU-H前列腺癌细胞的弱结合。FACS分析表明,AG-73肽在一系列浓度范围内附着于肿瘤细胞表面,而RU-1肽显示出附着所需的均匀浓度。所描述的筛选随机肽库的策略具有三个优点:(i)可以使用活细胞分离黏附的构象敏感受体的配体;(ii)可以使用功能阻断抗体选择特异性结合;(iii)可以区分支持黏附而与铺展特性无关的肽。原则上,对于任何有功能阻断试剂可用的上皮细胞表面受体,都可以在不了解序列的情况下分离出特异性黏附肽。